The Valley Desk

NCT04567550 · Interventional trial

RGX-314 Gene Therapy Administered in the Suprachoroidal Space for Participants With Diabetic Retinopathy (DR) With and Without Center Involved-Diabetic Macular Edema (CI-DME)

Overall registry status Completed

Phase 2

Conditions Center-Involved Diabetic Macular Edema (CI-DME), Diabetic Retinopathy (DR)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov